Penicillin Allergy and Other Drug Allergies Before Cosmetic Surgery: Why the Label Changes Your Antibiotic, Whether Cefazolin Is Safe, What a Lidocaine, Latex, or Chlorhexidine Allergy Really Means, and When to See an Allergist First

The patient is 44, booked for a breast lift with implants, and the intake form asks for drug allergies. They write "penicillin," as they have on every medical form since childhood. They have no memory of the reaction. Their mother once told them it was a rash during an ear infection when they were four. Nobody at the consultation asks about it, the pre-op paperwork lists it in red, and on the morning of surgery the anesthesiologist, reading that red line, reaches past the standard antibiotic for a second-choice drug that covers the skin bacteria less well and carries its own set of problems.

That sequence plays out across American operating rooms every day, and it is one of the more fixable risks in elective surgery. A penicillin allergy label is the most common drug allergy label in the country, and the large majority of people carrying it can take penicillin safely. The same pattern of overcalled or misunderstood allergies applies to local anesthetics, sulfa drugs, codeine, iodine, and latex. Meanwhile, a handful of genuine allergies that matter a great deal in surgery, notably to chlorhexidine and to certain anesthetic drugs, often go unrecorded because patients have never connected a past reaction to its cause. What follows is why the allergy list matters more in surgery than almost anywhere else, how penicillin labels change antibiotic choice and how to clear a wrong one, which reactions to local anesthetics and pain medicine are not allergies, the hidden exposures in an operating room, and what to do about injectables and past reactions under anesthesia.

Why the allergy list matters more in surgery than almost anywhere else

The short answer: the allergy list decides which antibiotic is given minutes before the first incision, which skin prep is used, which gloves are worn, and which drugs are avoided under anesthesia, so a wrong label quietly worsens the operation and a missing one can cause a reaction in a patient who cannot speak up.

Most cosmetic operations are clean procedures, and the preventive antibiotic given within an hour before incision is one of the few infection measures with solid evidence behind it, as covered in the earlier piece on antibiotics after cosmetic surgery. The 2013 clinical practice guidelines on antimicrobial prophylaxis in surgery, issued jointly by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Surgical Infection Society, and the Society for Healthcare Epidemiology of America, name cefazolin, a first-generation cephalosporin, as the preferred agent for most clean procedures, including plastic surgery and breast surgery with implants. Cefazolin is inexpensive, covers the staphylococci and streptococci that live on skin, reaches tissue quickly, and has a long safety record.

The problem is that cefazolin belongs to the same broad beta-lactam family as penicillin, and for decades a penicillin label pushed surgical teams toward alternatives: clindamycin or vancomycin. The CDC estimates that about 10 percent of patients in the United States report a penicillin allergy, while fewer than 1 percent of the population is truly allergic. That gap has measurable consequences. A 2018 study in Clinical Infectious Diseases by Kimberly Blumenthal and colleagues at Massachusetts General Hospital, covering more than 8,000 surgical patients, found that a reported penicillin allergy was associated with roughly 50 percent higher odds of surgical site infection, and the excess risk was explained by patients receiving second-line antibiotics instead of cefazolin.

For a cosmetic patient, a surgical site infection is not a minor inconvenience. Around a breast implant it can mean removal of the device; it is also one of the factors implicated in the biofilm theory of capsular contracture. After a tummy tuck or facelift it can mean wound breakdown and a worse scar. The label also follows the patient beyond surgery: the dental antibiotic decisions discussed in the piece on dental work after breast implants run into the same problem.

The other side of the ledger is genuine allergy that never makes it onto the form. The Royal College of Anaesthetists' Sixth National Audit Project (NAP6), published in 2018 and the largest prospective study of anaphylaxis during anesthesia, estimated perioperative anaphylaxis at roughly 1 in 10,000 anesthetics. Antibiotics were the leading cause, followed by neuromuscular blocking drugs (the muscle relaxants used with a breathing tube), chlorhexidine, and patent blue dye. Under anesthesia, the usual warning signs (itching, throat tightness, a sense of doom) are invisible, and a rash may be hidden under drapes, so reactions often announce themselves as a sudden, severe drop in blood pressure or trouble ventilating the lungs. That is why the history the patient gives before surgery carries so much weight.

Penicillin, cefazolin, and clearing a label that is probably wrong

The short answer: most penicillin labels can be removed with a short allergist evaluation, often just a supervised dose of amoxicillin, and even without testing, current allergy guidance supports giving cefazolin to most patients with a penicillin label, so the conversation should happen weeks before surgery rather than in the preoperative bay.

Penicillin labels are wrong for several reasons. Many date from childhood, when a viral rash that happened to coincide with amoxicillin was blamed on the drug. Some describe side effects, such as nausea or diarrhea, rather than allergy. Some were inherited from a parent's history. And genuine IgE-mediated penicillin allergy fades: the CDC notes that about 80 percent of people with a true penicillin allergy lose that sensitivity within ten years.

The 2022 drug allergy practice parameter update from the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology, published in the Annals of Allergy, Asthma and Immunology, made two changes that matter for surgical patients. First, it endorsed direct oral challenge, a single supervised dose of amoxicillin followed by an hour or so of observation, for patients with a low-risk history, without skin testing first. The PALACE trial, published in JAMA Internal Medicine in 2023, supported that approach: in low-risk adults identified with a scoring tool called PEN-FAST, a direct oral challenge was as safe as the traditional skin test followed by challenge. PEN-FAST, developed by Jason Trubiano and colleagues, asks whether the reaction was within the past five years, whether it involved anaphylaxis, angioedema, or a severe skin reaction, and whether it required treatment. Second, the parameter noted that cefazolin has a side chain not shared by any penicillin or other commonly used cephalosporin, making meaningful cross-reactivity rare, and suggested that patients with a penicillin allergy history can generally receive cefazolin without testing.

"The red line on the intake form does not prevent an allergic reaction for most of the people who carry it. It mostly prevents them from getting the antibiotic most reliably effective against skin bacteria."

Many hospitals now follow that guidance, but practice varies, especially in office-based surgical suites, and individual anesthesiologists and surgeons make the final call. The practical answer is to raise the label at the consultation and ask which antibiotic the team plans to use. If the answer is clindamycin or vancomycin solely because of a childhood label, an allergist visit before surgery is worth scheduling. It is usually a single appointment, and it permanently changes the record. Ask for written documentation of the result, because a label removed in an allergist's office has a way of reappearing in the next system's chart.

The alternatives are not bad drugs, but each carries trade-offs. Clindamycin is the antibiotic most strongly associated with Clostridioides difficile colitis, a serious diarrheal infection, and resistance among skin staphylococci has risen. Vancomycin covers resistant staph but is less effective than cefazolin against the ordinary, susceptible strains, and it must be infused slowly, over at least an hour, which complicates timing; infused too fast, it causes flushing and itching (vancomycin infusion reaction, once called red man syndrome), which is not an allergy, though it is often recorded as one.

Patients with a genuine, high-risk history are different. A past reaction involving anaphylaxis, swelling of the face or throat, blistering, peeling skin, or organ involvement (such as Stevens-Johnson syndrome, toxic epidermal necrolysis, or DRESS) should be evaluated by an allergist rather than tested casually, and severe delayed skin reactions are generally a reason to avoid the drug permanently. A real but limited penicillin allergy still usually permits cefazolin; that decision belongs to the allergist and anesthesia team together.

Sulfa labels raise a related confusion. An allergy to sulfonamide antibiotics, such as sulfamethoxazole-trimethoprim, sometimes prescribed when resistant staph is a concern, does not reliably predict reactions to non-antibiotic drugs that contain a sulfonamide group. A 2003 study by Brian Strom and colleagues in the New England Journal of Medicine found that patients who reacted to sulfonamide antibiotics were somewhat more likely to react to non-antibiotic sulfonamides, but no more than they were to react to penicillin, which pointed to a general tendency toward drug reactions rather than true cross-reactivity. This matters because celecoxib, a common ingredient in opioid-sparing recovery plans, carries an FDA label contraindication for patients with sulfonamide allergy. Some teams avoid it; others use it after weighing the history. The patient should know which, and why.

Lidocaine, codeine, and the reactions that are not allergies

The short answer: true allergy to amide local anesthetics such as lidocaine is very rare, and most reactions patients remember (a racing heart at the dentist, fainting, itching from codeine, vomiting from pain pills) are side effects or toxicity, which matter but call for different precautions than allergy.

Local anesthetic is part of nearly every cosmetic procedure, from filler with built-in lidocaine to the tumescent fluid in liposuction to the long-acting bupivacaine injected at the end of a breast augmentation. Patients who believe they are allergic to it face real obstacles, because the alternatives are general anesthesia for procedures that would otherwise need none, or more pain afterward. Allergists who have formally tested patients referred for suspected local anesthetic allergy have found genuine IgE-mediated allergy in well under 1 percent of cases in most series.

What patients usually remember is something else:

• Epinephrine effects. Most dental and surgical local anesthetic is mixed with epinephrine to reduce bleeding and prolong numbness. It can cause a pounding heart, shakiness, and anxiety for several minutes, which feels alarming and is often recorded as an allergy.
• Vasovagal reactions. Fainting, sweating, pallor, and nausea at the sight of a needle are a reflex, not a drug reaction.
• Toxicity. Too much local anesthetic absorbed too fast causes metallic taste, ringing ears, numb lips, and in severe cases seizures and heart rhythm problems. This is a dose problem, covered in the piece on lidocaine toxicity in tumescent liposuction, and it is not an allergy.
• Preservatives and the older drug class. Multi-dose vials may contain methylparaben, and ester-type anesthetics (benzocaine, tetracaine, procaine) break down to a compound called para-aminobenzoic acid that causes more genuine allergy than the amides (lidocaine, bupivacaine, ropivacaine, mepivacaine). Contact dermatitis from topical numbing creams containing esters is the most common true local anesthetic allergy.
• Anesthetic that does not work. Poor numbing is not an allergy either; it can reflect inflamed tissue, technique, or, in some patients, the local anesthetic resistance described in the piece on Ehlers-Danlos syndrome and cosmetic surgery.

An allergist can test local anesthetics with skin testing followed by a subcutaneous challenge of the specific drug, preservative-containing or not. That is worth doing before an operation planned around local anesthesia, because the result determines whether the anesthesia choice is open or forced.

Pain medications produce similar confusion. Codeine and morphine commonly cause itching and flushing by releasing histamine directly from skin cells, which is a predictable side effect rather than an allergy, and it does not rule out other opioids. Nausea and vomiting from opioids, addressed in the piece on nausea after cosmetic surgery, are side effects too. Recording them as allergies is not harmless; a long list of false allergies narrows the menu for pain control and nausea prevention. Aspirin and ibuprofen reactions are a distinct category, sometimes part of aspirin-exacerbated respiratory disease, discussed in the piece on asthma before cosmetic surgery, and those should be recorded precisely.

Latex, chlorhexidine, iodine, and the hidden exposures in an operating room

The short answer: chlorhexidine has become one of the more common causes of anaphylaxis during surgery and is easy to miss because it is in so many products, latex allergy is rarer than it once was but still requires a planned latex-safe room, and "iodine allergy" is mostly a myth that should not keep a patient from povidone-iodine skin prep.

Chlorhexidine is everywhere in surgery: in the antiseptic body wash patients are asked to use the night before and the morning of surgery, in the skin prep painted on the operative field, in some urinary catheter lubricants, in some IV line coatings, and in mouthwashes. In February 2017, the FDA issued a drug safety communication warning that rare but serious allergic reactions to chlorhexidine gluconate antiseptics had been increasing. NAP6 found it a significant cause of perioperative anaphylaxis, and allergists suspect it is underrecognized because a reaction minutes into an operation is usually attributed to the antibiotic or anesthetic given at the same time. Patients who have had hives or swelling after a pre-op wash, a dental procedure with chlorhexidine rinse, or a previous operation with no clear explanation should mention it. Povidone-iodine is the standard alternative skin prep.

That brings up iodine. There is no such thing as an allergy to iodine itself, an element the body needs. Shellfish allergy is caused by proteins such as tropomyosin, not iodine, and it does not predict reactions to iodine-containing antiseptics or contrast dye; the American Academy of Allergy, Asthma and Immunology has said so for years. Povidone-iodine can cause skin irritation and, uncommonly, contact allergy to the povidone component, but a shellfish allergy is not a reason to avoid it.

Latex allergy peaked among healthcare workers and patients with repeated surgery in the 1980s and 1990s, then fell sharply as hospitals moved to non-latex gloves, and in 2017 the FDA banned powdered medical gloves, whose powder carried latex proteins into the air. Patients with a true latex allergy still need the facility to know in advance so the room can be prepared, ideally as the first case of the day, with latex-safe gloves, catheters, tourniquets, blood pressure cuffs, and IV equipment. Many latex-allergic patients also react to banana, avocado, kiwi, and chestnut (the latex-fruit syndrome), which can be a clue for someone unsure of the history.

The remaining exposures cause skin reactions more often than anaphylaxis. Adhesive tapes, skin glue (2-octyl cyanoacrylate), and dressings produce contact dermatitis that can mimic infection, covered in the piece on adhesive and tape rash after cosmetic surgery. Topical antibiotic ointments containing neomycin or bacitracin are among the most common contact allergens in the country. Nickel allergy rarely matters for surgical instruments but can matter for staples, some jewelry left in place, and implanted hardware, which is part of why the rules in the piece on day-of-surgery rules for nail polish, jewelry, and contacts exist. Suture reactions occasionally look like an allergy and are usually a foreign body response, discussed in the piece on spitting sutures after cosmetic surgery.

Injectables, past reactions under anesthesia, and when to see an allergist first

The short answer: most injectable allergies are rare, with the notable exceptions of the enzyme used to dissolve filler and the lidocaine mixed into many products, and anyone who has had an unexplained reaction during a previous anesthetic should have it worked up by an allergist before another elective operation.

Hyaluronic acid filler itself rarely causes true allergy, although delayed inflammatory nodules occur and are sometimes triggered by infection or vaccination. The drug that deserves attention is hyaluronidase, the enzyme used to dissolve filler, including in the emergency treatment of filler vascular occlusion. Older formulations are derived from cow or sheep tissue; a recombinant human version also exists. Allergic reactions occur in a small fraction of patients, and bee and wasp venom contain their own hyaluronidase, so patients with a history of severe sting reactions may be at higher risk. Some injectors perform a skin test before elective dissolving, as discussed in the piece on whether dermal filler can be dissolved; in a vascular emergency, the benefit almost always outweighs that risk. Botulinum toxin allergy is rare, but the products differ in their accessory proteins and in whether they contain human albumin or, in one case, cow's milk protein, a distinction that matters for patients with a severe milk allergy and is touched on in the piece comparing Botox and Dysport.

A past reaction under anesthesia is the history that most warrants a specialist. If a previous operation involved an unexplained drop in blood pressure, wheezing, a widespread rash, an aborted procedure, or a stay in intensive care, the patient should request the anesthesia record from that facility. It lists every drug given and the timing, which is what an allergist needs. The usual suspects are antibiotics, neuromuscular blockers such as rocuronium and succinylcholine, the reversal agent sugammadex, chlorhexidine, and less commonly opioids, dyes, and latex. Allergists can test most of these, and the result often clears drugs that were wrongly blamed. A family history of a severe anesthetic reaction should also be raised, because malignant hyperthermia is a different, inherited muscle disorder rather than an allergy, and it changes which anesthetic gases can be used.

If a reaction does happen during surgery, a blood test for mast cell tryptase drawn within one to two hours, and repeated at least a day later for a baseline, helps confirm anaphylaxis. Accredited facilities are expected to stock epinephrine and have an anaphylaxis protocol; the piece on outpatient facility accreditation explains what those credentials do and do not guarantee. Patients with mast cell disorders, which overlap with the conditions in the piece on POTS and dysautonomia, or with multiple drug intolerances, often benefit from an allergist-designed premedication plan, though premedication with antihistamines and steroids does not prevent true anaphylaxis and is no substitute for avoiding the culprit.

The timing is the practical point. An allergist appointment, any testing, and the paperwork that follows take weeks, not days, which is why the allergy history belongs in the first consultation alongside preoperative testing and the supplement stop list. A surgical practice that never asks what happened during a listed reaction is missing an opportunity, and a second consultation can reveal how differently teams handle it.

The honest summary

The allergy list on a surgical intake form is treated as fixed truth, and much of it is not. A penicillin label is the clearest example: it is common, usually wrong, and in surgery it can trade the standard skin antibiotic for a weaker alternative and raise the odds of infection. Most patients with that label can have it removed with a short allergist visit, and current guidance supports cefazolin for most of them even without testing.

The same skepticism applies to many reported reactions to lidocaine, codeine, iodine, and sulfa, which are often side effects, toxicity, or myths. The reverse applies to chlorhexidine, latex, muscle relaxants, and any reaction that happened under a previous anesthetic, which deserve more attention than they usually get.

The core plan is simple. Write down what happened during each listed reaction, when, and how it was treated. Raise the list at the consultation and ask which antibiotic and skin prep the team plans to use. See an allergist weeks ahead if a label is old and vague, if it is forcing a second-line antibiotic, or if any past reaction during surgery was never explained. Bring the old anesthesia record. Remove false labels in writing, and keep the real ones precise. The goal is not a shorter list. It is a list that is true.